(Q42849548)

8 November 2017

title

Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats (English)

1 reference

8 November 2017

1 reference

1 reference

Hiroshi Kono

1

1 reference

8 November 2017

Hideki Fujii

2

1 reference

8 November 2017

Masahito Ogiku

3

1 reference

8 November 2017

Masato Tsuchiya

4

1 reference

8 November 2017

Kenichi Ishii

5

1 reference

8 November 2017

Michio Hara

6

1 reference

8 November 2017

publication date

24 August 2010

1 reference

8 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

Translational Research

1 reference

8 November 2017

volume

156

1 reference

8 November 2017

issue

5

1 reference

8 November 2017

page(s)

282-291

1 reference

AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease.

8 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Extraintestinal manifestations of inflammatory bowel disease: epidemiology, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Nutrition in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Importance of nutrition in inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Review article: Probiotics in gastrointestinal and liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Prebiotics in inflammatory bowel diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Medium-chain triglycerides enhance secretory IgA expression in rat intestine after administration of endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Short-term efficacy of enteral nutrition in the treatment of active Crohn's disease: a randomized, controlled trial comparing nutrient formulas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Experimental Production of Diffuse Colitis in Rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Tips for measuring endotoxin in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Medium-chain triglyceride-rich enteral nutrition is more effective than low-fat enteral nutrition in rat colitis, but is equal in enteritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Chemokine-leukocyte interactions. The voodoo that they do so well

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Cytokines in experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Role of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, in rat experimental colitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Experimental models of inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Treatment of endotoxemic mice with anti-interleukin-6 antibody paradoxically increases interleukin-6 levels and stimulates mucosal protein synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSL.2010.07.012

10.1016/J.TRSL.2010.07.012

7 January 2021

Identifiers

DOI

1 reference

8 November 2017

1 reference